Single-photon Emission Computed Tomography Market Size, Share & Trends Analysis Report By Product (Stand-alone SPECT Systems, Hybrid SPECT Systems), By Application (Cardiology, Oncology), By End Use, By Region, And Segment Forecasts, 2024 - 2030
Single-photon Emission Computed Tomography Market Growth & Trends
The global single-photon emission computed tomography market size is expected to reach USD 4.54 billion by 2030, registering a CAGR of 2.78% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by several key factors. One of the primary market drivers is the increasing prevalence of cancer. The increasing prevalence of chronic disorders such as cancer, cardiovascular diseases, and neurological conditions is a significant driver of the single-photon emission computed tomography (SPECT) market.
As the population ages, the incidence of these diseases rises, creating a greater demand for accurate diagnostic tools such as SPECT imaging. This trend necessitates the adoption of advanced imaging technologies that can provide detailed insights into disease progression and treatment efficacy, thereby boosting the SPECT market in the region.
Government support through funding for healthcare facilities and initiatives to improve access to advanced imaging technologies is further propelling market growth. In addition, the integration of SPECT with other imaging modalities, such as CT (SPECT/CT), enhances diagnostic accuracy and expands its applications in various medical fields.Manufacturers and healthcare providers are actively collaborating to advance SPECT technology and expand its use in clinical practice.
Major players in the market, such as Cardinal Health, GE Healthcare, and Siemens Healthineers, are investing in research and development to innovate and optimize SPECT systems. These companies are also forming partnerships with hospitals and research institutions to facilitate clinical trials and the introduction of new radiopharmaceuticals, which are essential for SPECT imaging. The collaboration between manufacturers and healthcare facilities ensures that the latest technologies are readily available to clinicians, thereby improving patient outcomes.
The launch of new products and the integration of cutting-edge technologies are key trends in the SPECT market. Recent advancements include the development of high-resolution imaging systems and novel radiopharmaceuticals that enhance the sensitivity and specificity of SPECT scans. For instance, the introduction of a cutting-edge scanner is expected to transform nuclear medicine services at QEII Health Sciences Centre by providing clinicians with enhanced tools for better diagnosis and treatment planning. This aligns with the center's commitment to delivering high-quality healthcare through the adoption of innovative technologies. Such scanner's installation represents a significant investment in healthcare infrastructure, aimed at improving patient outcomes.
Further, the introduction of hybrid imaging systems such as SPECT/CT in hospital settings has revolutionized the field by providing comprehensive anatomical and functional imaging, which is crucial for accurate diagnosis and treatment planning. For instance, in May 2024, Mercy Sullivan Hospital installed a high-tech SPECT/CT imaging system, enhancing its diagnostic capabilities. The new system, which integrates advanced SPECT and CT technologies, was designed to provide detailed and accurate imaging for a variety of medical conditions.
The installation marked a significant upgrade for the hospital, improving its ability to diagnose and monitor diseases more effectively. The new SPECT/CT system aims to support better patient care by offering higher resolution images and more precise diagnostic information.These innovations not only improve diagnostic capabilities but also foster greater interdisciplinary collaboration among healthcare professionals, leading to more effective patient management strategies.
Some of the key players in the market are GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Spectrum Dynamics Medical, Digirad Corporation, MILabs B.V., Mediso Medical Imaging Systems, MiE GmbH. Key player are involved in undertaking strategic initiatives such as product launch to cater global clientele. In October 2022, Spectrum Dynamics announced its advancement in digital nuclear medicine imaging with the launch of the VERITON-CT-400 Series Digital SPECT/CT scanners. These new scanners utilize solid-state detector technology and feature a wide-bore configuration, enabling them to image high-energy isotopes with enhanced precision and capability.
Single-photon Emission Computed Tomography Market Report Highlights
- Based on product, hybrid SPECT systems accounted for largest revenue share of 67.12% in 2023. These hybrid systems integrate SPECT's functional imaging capabilities with the anatomical detail provided by CT or MRI, offering a comprehensive view that enhances diagnostic accuracy and treatment planning. Hybrid SPECT systems are used in various medical applications, including oncology, cardiology, and neurology, to provide detailed insights into the physiological and anatomical aspects of the body
- Based on application, oncology dominated the market and accounted for the largest share of 49.58% in 2023. The rising global incidence of cancer is driving the growth of the nuclear imaging market, particularly in PET and SPECT technologies. These advanced modalities have gained widespread adoption due to their unparalleled ability to visualize the molecular characteristics of cancer, providing a deeper understanding of the disease
- Based on end use, hospitals segment is dominated the end use segments with the largest market share of 46.9% in 2023. This is attributable to advanced imaging technologies in hospitals that enable the early detection of cancer, CVD’s, allowing for prompt intervention and treatment. In addition, partnerships & collaborations between hospitals and other companies to meet clinical needs contribute to market growth
- North America dominated the global market due to the attributed to the well-established healthcare sector, commitment to innovation, advanced infrastructure, a strong emphasis on R&D, the high prevalence of cancer and chronic diseases, and rapid adoption of innovative technologies
- Asia Pacific region is expected to witness fastest growth with a CAGR of 3.51% over the forecast period from 2024 to 2030, due to presence of manufacturers with innovative devices manufacturing capabilities coupled with accelerated diagnostic research capabilities
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. End Use
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR’s internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in North America
- 1.4.5.2. Data for primary interviews in Europe
- 1.4.5.3. Data for primary interviews in Asia Pacific
- 1.4.5.4. Data for primary interviews in Latin America
- 1.4.5.5. Data for Primary interviews in MEA
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. End use outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
- Chapter 3. Single-Photon Emission Computed Tomography (SPECT) Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Rising prevalence of cancer
- 3.2.1.2. Technological advancements
- 3.2.1.3. Increasing awareness of diagnostic needs
- 3.2.2. Market restraint analysis
- 3.2.2.1. lack of skilled professionals
- 3.3. Single-Photon Emission Computed Tomography (SPECT) Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- Chapter 4. Single-Photon Emission Computed Tomography (SPECT) Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Global Single-Photon Emission Computed Tomography (SPECT) Product Market Movement Analysis
- 4.3. Global Single-Photon Emission Computed Tomography (SPECT) Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. Stand-alone SPECT Systems
- 4.4.1. Stand-alone SPECT systems market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5. Hybrid SPECT Systems
- 4.5.1. Hybrid SPECT systems market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 5. Single-Photon Emission Computed Tomography (SPECT) Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Global Single-Photon Emission Computed Tomography (SPECT) Application Market Movement Analysis
- 5.3. Global Single-Photon Emission Computed Tomography (SPECT) Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.5. Cardiology
- 5.5.1. Cardiology market estimates and forecasts 2018 to 2030 (USD Million)
- 5.6. Oncology
- 5.6.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
- 5.7. Neurology
- 5.7.1. Neurology market estimates and forecasts 2018 to 2030 (USD Million)
- 5.8. Other Application
- 5.8.1. Other application market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 6. Single-Photon Emission Computed Tomography (SPECT) Market: End Use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Global Single-Photon Emission Computed Tomography (SPECT) End Use Market Movement Analysis
- 6.3. Global Single-Photon Emission Computed Tomography (SPECT) Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
- 6.4. Hospitals
- 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5. Diagnostic Imaging Centers
- 6.5.1. Diagnostic imaging centers market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6. Others
- 6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 7. Single-Photon Emission Computed Tomography (SPECT) Market: Regional Estimates & Trend Analysis By Product, Application, End Use
- 7.1. Regional Market Share Analysis, 2023 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Global Regional Market Snapshot
- 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 7.5. North America
- 7.5.1. U.S.
- 7.5.1.1. Key country dynamics
- 7.5.1.2. Competitive scenario
- 7.5.1.3. Regulatory framework/ reimbursement structure
- 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.2. Canada
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Competitive scenario
- 7.5.2.3. Regulatory framework/ reimbursement structure
- 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.3. Mexico
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Competitive scenario
- 7.5.3.3. Regulatory framework/ reimbursement structure
- 7.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6. Europe
- 7.6.1. Regulatory framework/ reimbursement structure
- 7.6.2. UK
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Competitive scenario
- 7.6.2.3. Regulatory framework/ reimbursement structure
- 7.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.3. Germany
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Competitive scenario
- 7.6.3.3. Regulatory framework/ reimbursement structure
- 7.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.4. France
- 7.6.4.1. Key country dynamics
- 7.6.4.2. Competitive scenario
- 7.6.4.3. Regulatory framework/ reimbursement structure
- 7.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.5. Italy
- 7.6.5.1. Key country dynamics
- 7.6.5.2. Competitive scenario
- 7.6.5.3. Regulatory framework/ reimbursement structure
- 7.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.6. Spain
- 7.6.6.1. Key country dynamics
- 7.6.6.2. Competitive scenario
- 7.6.6.3. Regulatory framework/ reimbursement structure
- 7.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.7. Norway
- 7.6.7.1. Key country dynamics
- 7.6.7.2. Competitive scenario
- 7.6.7.3. Regulatory framework/ reimbursement structure
- 7.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.8. Sweden
- 7.6.8.1. Key country dynamics
- 7.6.8.2. Competitive scenario
- 7.6.8.3. Regulatory framework/ reimbursement structure
- 7.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.9. Denmark
- 7.6.9.1. Key country dynamics
- 7.6.9.2. Competitive scenario
- 7.6.9.3. Regulatory framework/ reimbursement structure
- 7.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7. Asia Pacific
- 7.7.1. Regulatory framework/ reimbursement structure
- 7.7.2. Japan
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Competitive scenario
- 7.7.2.3. Regulatory framework/ reimbursement structure
- 7.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.3. China
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Competitive scenario
- 7.7.3.3. Regulatory framework/ reimbursement structure
- 7.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.4. India
- 7.7.4.1. Key country dynamics
- 7.7.4.2. Competitive scenario
- 7.7.4.3. Regulatory framework/ reimbursement structure
- 7.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.5. Australia
- 7.7.5.1. Key country dynamics
- 7.7.5.2. Competitive scenario
- 7.7.5.3. Regulatory framework/ reimbursement structure
- 7.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.6. South Korea
- 7.7.6.1. Key country dynamics
- 7.7.6.2. Competitive scenario
- 7.7.6.3. Regulatory framework/ reimbursement structure
- 7.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.7. Thailand
- 7.7.7.1. Key country dynamics
- 7.7.7.2. Competitive scenario
- 7.7.7.3. Regulatory framework/ reimbursement structure
- 7.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8. Latin America
- 7.8.1. Regulatory framework/ reimbursement structure
- 7.8.2. Brazil
- 7.8.2.1. Key country dynamics
- 7.8.2.2. Competitive scenario
- 7.8.2.3. Regulatory framework/ reimbursement structure
- 7.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.3. Argentina
- 7.8.3.1. Key country dynamics
- 7.8.3.2. Competitive scenario
- 7.8.3.3. Regulatory framework/ reimbursement structure
- 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9. MEA
- 7.9.1. Regulatory framework/ reimbursement structure
- 7.9.2. South Africa
- 7.9.2.1. Key country dynamics
- 7.9.2.2. Competitive scenario
- 7.9.2.3. Regulatory framework/ reimbursement structure
- 7.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.3. Saudi Arabia
- 7.9.3.1. Key country dynamics
- 7.9.3.2. Competitive scenario
- 7.9.3.3. Regulatory framework/ reimbursement structure
- 7.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.4. UAE
- 7.9.4.1. Key country dynamics
- 7.9.4.2. Competitive scenario
- 7.9.4.3. Regulatory framework/ reimbursement structure
- 7.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.5. Kuwait
- 7.9.5.1. Key country dynamics
- 7.9.5.2. Competitive scenario
- 7.9.5.3. Regulatory framework/ reimbursement structure
- 7.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.3. Key company market share analysis, 2023
- 8.4. Company Position Analysis
- 8.5. Company Categorization (Emerging Players, Innovators and Leaders
- 8.6. Company Profiles
- 8.6.1. GE Healthcare
- 8.6.1.1. Company overview
- 8.6.1.2. Financial performance
- 8.6.1.3. Application benchmarking
- 8.6.1.4. Strategic initiatives
- 8.6.2. Siemens Healthineers
- 8.6.2.1. Company overview
- 8.6.2.2. Financial performance
- 8.6.2.3. Application benchmarking
- 8.6.2.4. Strategic initiatives
- 8.6.3. Koninklijke Philips N.V.
- 8.6.3.1. Company overview
- 8.6.3.2. Financial performance
- 8.6.3.3. Application benchmarking
- 8.6.3.4. Strategic initiatives
- 8.6.4. Spectrum Dynamics Medical
- 8.6.4.1. Company overview
- 8.6.4.2. Financial performance
- 8.6.4.3. Application benchmarking
- 8.6.4.4. Strategic initiatives
- 8.6.5. Digirad Corporation
- 8.6.5.1. Company overview
- 8.6.5.2. Financial performance
- 8.6.5.3. Application benchmarking
- 8.6.5.4. Strategic initiatives
- 8.6.6. MILabs B.V.
- 8.6.6.1. Company overview
- 8.6.6.2. Financial performance
- 8.6.6.3. Application benchmarking
- 8.6.6.4. Strategic initiatives
- 8.6.7. Mediso Medical Imaging Systems
- 8.6.7.1. Company overview
- 8.6.7.2. Financial performance
- 8.6.7.3. Application benchmarking
- 8.6.7.4. Strategic initiatives
- 8.6.8. MiE GmbH
- 8.6.8.1. Company overview
- 8.6.8.2. Financial performance
- 8.6.8.3. Application benchmarking
- 8.6.8.4. Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook